These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1840766)

  • 1. Performance on psychological tests. Demographic and clinical correlates of the results of these tests.
    Frith CD; Leary J; Cahill C; Johnstone EC
    Br J Psychiatry Suppl; 1991 Oct; (13):26-9, 44-6. PubMed ID: 1840766
    [No Abstract]   [Full Text] [Related]  

  • 2. No, it is not possible to be schizophrenic yet neuropsychologically normal.
    Wilk CM; Gold JM; McMahon RP; Humber K; Iannone VN; Buchanan RW
    Neuropsychology; 2005 Nov; 19(6):778-86. PubMed ID: 16351353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are relational style and neuropsychological performance predictors of social attributions in chronic schizophrenia?
    Donohoe G; Spoletini I; McGlade N; Behan C; Hayden J; O'Donoghue T; Peel R; Haq F; Walker C; O'Callaghan E; Spalletta G; Gill M; Corvin A
    Psychiatry Res; 2008 Oct; 161(1):19-27. PubMed ID: 18789541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality of life in bipolar type I disorder and schizophrenia in remission: clinical and neurocognitive correlates.
    Brissos S; Dias VV; Carita AI; Martinez-Arán A
    Psychiatry Res; 2008 Jul; 160(1):55-62. PubMed ID: 18485488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The association between cognition and functional outcome in first-episode patients with schizophrenia: mystery resolved?
    van Winkel R; Myin-Germeys I; De Hert M; Delespaul P; Peuskens J; van Os J
    Acta Psychiatr Scand; 2007 Aug; 116(2):119-24. PubMed ID: 17650273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An analysis of the cognitive deficit of schizophrenia based on the Piaget developmental theory.
    Torres A; Olivares JM; Rodriguez A; Vaamonde A; Berrios GE
    Compr Psychiatry; 2007; 48(4):376-9. PubMed ID: 17560960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [InSka (Intentionality Scale)--a new psychopathometric instrument for the detection of schizophrenic residual symptoms].
    Mundt C; Fiedler P; Pracht B; Rettig R
    Nervenarzt; 1985 Mar; 56(3):146-9. PubMed ID: 3990882
    [No Abstract]   [Full Text] [Related]  

  • 8. Humor appreciation deficit in schizophrenia: the relevance of basic neurocognitive functioning.
    Bozikas VP; Kosmidis MH; Giannakou M; Anezoulaki D; Petrikis P; Fokas K; Karavatos A
    J Nerv Ment Dis; 2007 Apr; 195(4):325-31. PubMed ID: 17435483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of clustering solutions for cognitive heterogeneity in schizophrenia.
    Goldstein G; Allen DN; Seaton BE
    J Int Neuropsychol Soc; 1998 Jul; 4(4):353-62. PubMed ID: 9656609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Psychopathology and follow-up of post-acute schizophrenia].
    Kick HA
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 63():1-145. PubMed ID: 1886622
    [No Abstract]   [Full Text] [Related]  

  • 11. A rating instrument for the evaluation of in-patient rehabilitation programmes in China. Results of reliability and validity testing.
    Li G; Hu X; Jin D; Tian W; Phillips MR
    Br J Psychiatry Suppl; 1994 Aug; (24):58-65. PubMed ID: 7946233
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theory of mind performance in schizophrenia: diagnostic, symptom, and neuropsychological correlates.
    Greig TC; Bryson GJ; Bell MD
    J Nerv Ment Dis; 2004 Jan; 192(1):12-8. PubMed ID: 14718771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition.
    Penadés R; Gastó C; Boget T; Catalán R; Salamero M
    Compr Psychiatry; 2001; 42(1):64-9. PubMed ID: 11154718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reliability and validity of the Test of Adaptive Behavior in Schizophrenia (TABS).
    Velligan DI; Diamond P; Glahn DC; Ritch J; Maples N; Castillo D; Miller AL
    Psychiatry Res; 2007 May; 151(1-2):55-66. PubMed ID: 17379319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formal thought disorder, neuropsychology and insight in schizophrenia.
    Barrera A; McKenna PJ; Berrios GE
    Psychopathology; 2009; 42(4):264-9. PubMed ID: 19521143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-year outcomes in first admission adolescent inpatients: clinical and cognitive characteristics at admission as predictors.
    Pogge DL; Insalaco B; Bertisch H; Bilginer L; Stokes J; Cornblatt BA; Harvey PD
    Psychiatry Res; 2008 Jul; 160(1):47-54. PubMed ID: 18534688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of outcome three years after diagnosis of first episode psychosis.
    Lucas S; Redoblado-Hodge MA; Shores A; Brennan J; Harris A
    Psychiatry Res; 2008 Oct; 161(1):11-8. PubMed ID: 18786728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neuropsychological basis of competence to consent in first-episode schizophrenia: a pilot metacognitive study.
    Koren D; Poyurovsky M; Seidman LJ; Goldsmith M; Wenger S; Klein EM
    Biol Psychiatry; 2005 Mar; 57(6):609-16. PubMed ID: 15780847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia and intellectual decline.
    David A
    Am J Psychiatry; 1998 Nov; 155(11):1634-5; author reply 1636-7. PubMed ID: 9812145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.